- Home
- CMPX vs PZC Comparison
CMPX vs PZC Comparison
Compare CMPX & PZC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CMPX
- PZC
- Stock Information
- Founded
- CMPX 2014
- PZC 2002
- Country
- CMPX United States
- PZC United States
- Employees
- CMPX N/A
- PZC N/A
- Industry
- CMPX Biotechnology: Pharmaceutical Preparations
- PZC Investment Managers
- Sector
- CMPX Health Care
- PZC Finance
- Exchange
- CMPX Nasdaq
- PZC Nasdaq
- Market Cap
- CMPX 217.4M
- PZC 163.2M
- IPO Year
- CMPX N/A
- PZC N/A
- Fundamental
- Price
- CMPX $1.63
- PZC $7.49
- Analyst Decision
- CMPX Strong Buy
- PZC
- Analyst Count
- CMPX 3
- PZC 0
- Target Price
- CMPX $7.67
- PZC N/A
- AVG Volume (30 Days)
- CMPX 410.9K
- PZC 48.2K
- Earning Date
- CMPX 11-07-2024
- PZC 01-01-0001
- Dividend Yield
- CMPX N/A
- PZC 4.68%
- EPS Growth
- CMPX N/A
- PZC N/A
- EPS
- CMPX N/A
- PZC N/A
- Revenue
- CMPX $850,000.00
- PZC N/A
- Revenue This Year
- CMPX N/A
- PZC N/A
- Revenue Next Year
- CMPX $950.68
- PZC N/A
- P/E Ratio
- CMPX N/A
- PZC N/A
- Revenue Growth
- CMPX N/A
- PZC N/A
- 52 Week Low
- CMPX $0.77
- PZC $6.30
- 52 Week High
- CMPX $2.34
- PZC $8.20
- Technical
- Relative Strength Index (RSI)
- CMPX 62.58
- PZC 67.63
- Support Level
- CMPX $1.42
- PZC $7.26
- Resistance Level
- CMPX $1.86
- PZC $7.55
- Average True Range (ATR)
- CMPX 0.15
- PZC 0.06
- MACD
- CMPX 0.01
- PZC 0.02
- Stochastic Oscillator
- CMPX 62.09
- PZC 81.82
About CMPX Compass Therapeutics Inc.
Compass Therapeutics Inc is a clinical-stage biopharmaceutical company that develops proprietary antibody therapeutics intended to engage the immune system to treat both solid tumors and hematological malignancies. It is engaged in drug discovery by leveraging its proprietary antibody discovery engine to broadly drug the immune system and identify optimal combinations empirically. Through StitchMabs and common light chain platforms, these combinatorial insights can be rapidly translated into tailored bispecifics with monoclonal-like manufacturability. Its pipeline is comprised of three product candidates, CTX-009, CTX-471, and CTX-8371.
About PZC PIMCO California Municipal Income Fund III of Beneficial Interest
PIMCO CA Muni Income Fund III operates as a closed-end management investment company. The investment objective of the fund is to seek to provide current income exempt from federal and California income tax. Its portfolio of investments includes investment in different sectors such as education, healthcare, industrial and others.